Agilent Technologies (A) Peer Comparison
$153.85
$-3.84
(-2.44%)
As on 28-Aug-2026 16:10EDT
Market cap
$44,907 Mln
Revenue (TTM)
$7,232 Mln
P/E Ratio
31.4
P/B Ratio
6.2
Div. Yield
0.6 %
Edit
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
44,907 | 118,142 | 40,697 | 32,953 | 13,880 |
Revenue ($ Mln) |
7,232 | 36,364 | 3,319 | 5,653 | 4,231 |
Net Profit ($ Mln) |
1,414.00 | 4,800.00 | 941.65 | 1,523.29 | 235.80 |
Net Margin (%) |
19.55 | 13.20 | 28.37 | 26.94 | 5.57 |
RoE (%) |
20.40 | 9.85 | 13.13 | 24.27 | 2.86 |
Price to Earnings |
31.36 | 25.22 | 44.42 | 22.11 | 60.31 |
Price-To-Book |
6.20 | 2.44 | 5.58 | 5.05 | 1.68 |
Income Statement ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
6,948.00 | 33,537.00 | 2,746.62 | 5,653.44 | 4,092.40 |
|
Cost of Revenue
|
3,305.00 | 11,632.00 | 699.64 | 2,195.77 | 1,609.50 |
|
Gross Profit
|
3,643.00 | 21,905.00 | 2,046.98 | 3,054.97 | 2,482.90 |
|
Operating Expenses
|
2,164.00 | 15,950.00 | 1,355.55 | 1,565.03 | 1,800.00 |
|
Operating Profit (EBIT)
|
1,479.00 | 5,955.00 | 691.44 | 1,892.65 | 682.90 |
|
Other Income
|
-- | -- | -- | 0.00 | -- |
|
Profit before Tax
|
1,435.00 | 5,628.00 | 919.38 | 1,919.42 | 566.50 |
|
Provision for Tax
|
132.00 | 936.00 | 205.24 | 396.12 | 191.60 |
|
Profit after Tax (Net Income)
|
1,303.00 | 4,662.00 | 714.14 | 1,523.29 | 374.90 |
|
Minority Interest
|
-- | -- | -- | 0.00 | -- |
|
Consolidated Profit
|
1,303.00 | 4,662.00 | -- | 741.13 | -- |
Liabilities ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
6,741.00 | 48,024.00 | 5,832.37 | 6,585.39 | 8,238.90 |
|
Minority Interest
|
-- | -- | -- | 0.00 | -- |
|
Non-Current Liabilities
|
3,639.00 | 30,545.00 | 108.98 | 985.45 | 3,042.90 |
|
Current Liabilities
|
2,347.00 | 12,879.00 | 1,398.40 | 1,395.11 | 1,112.80 |
|
Total Liabilities
|
12,727.00 | 91,680.00 | 7,339.76 | 8,174.39 | 12,394.80 |
Assets ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
8,133.00 | 67,865.00 | 1,030.95 | 4,641.21 | 10,288.40 |
|
Current Assets
|
4,594.00 | 23,814.00 | 6,308.80 | 4,324.74 | 2,106.40 |
|
Total Assets
|
12,727.00 | 91,680.00 | 7,339.76 | 8,174.39 | 12,394.80 |
|
Total Debt*
|
3,354.00 | 28,516.00 | 75.78 | 825.92 | 2,783.60 |
|
Net Current Assets
|
2,247.00 | 10,935.00 | 4,910.40 | 0.00 | 993.60 |
Cashflow ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1,559.00 | 7,044.00 | 1,090.05 | 1,751.59 | 796.10 |
|
Cash Flow from Investing Activities
|
-394.00 | -1,937.00 | -700.14 | -200.05 | -372.90 |
|
Cash from Financing Activities
|
-715.00 | -4,361.00 | 26.12 | -606.25 | -425.90 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.32 | 6.14 | 13.46 | 22.31 | 3.46 |
|
ROE (%)
|
20.62 | 9.49 | 13.63 | 23.61 | 4.59 |
|
ROA (%)
|
10.61 | 5.13 | 10.78 | 13.55 | 3.03 |
|
EBIT Margin (%)
|
-- | -- | -- | 34.46 | -- |
|
Net Margin (%)
|
18.75 | 13.90 | 26.00 | 26.94 | 9.16 |
|
Cash Profit Margin (%)
|
-- | -- | -- | 0.00 | -- |
Growth Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.07 | 0.04 | 0.16 | 9.85 | 0.05 |
|
EBIT Growth (%)
|
-- | -- | -- | 15.44 | -- |
|
Net Profit Growth (%)
|
1.09 | 26.82 | 35.84 | 8.75 | -4.44 |
|
EPS Growth (%)
|
-- | -- | -- | 9.37 | -- |
|
Book Value Growth (%)
|
-- | -- | -- | 11.92 | -- |
Valuation Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | 27.08 | -- |
|
Price / Book Value
|
-- | -- | -- | 6.36 | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
0.85 | 2.12 | -5.29 | 19.63 | 2.54 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.50 | 0.59 | 0.01 | 0.00 | 0.34 |
|
Short term debt to equity ratio
|
0.05 | 0.06 | 0.00 | 0.04 | 0.01 |
|
Current Ratio
|
1.96 | 1.85 | 4.51 | 3.10 | 1.89 |
|
Quick Ratio
|
1.52 | 1.42 | -- | 2.42 | 1.13 |
|
Interest Coverage
|
13.81 | 8.72 | -- | 39.45 | 6.30 |
Operating Efficiency Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
21.40 | 19.43 | 38.49 | 18.33 | 20.26 |
|
Asset Turnover
|
0.57 | 0.37 | 0.41 | 0.50 | 0.33 |
|
Receivable days
|
73.89 | 68.85 | 129.37 | 64.87 | 68.99 |
|
Inventory Days
|
111.40 | 167.88 | 0.00 | 152.81 | 187.07 |
|
Payable days
|
61.34 | 76.29 | 16.17 | 45.05 | 63.64 |
|
Cash Conversion Cycle
|
123.95 | 160.44 | 109.59 | 172.63 | 192.42 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
